Free Trial
TSE:CMED

CanniMed Therapeutics (CMED) Stock Price, News & Analysis

CanniMed Therapeutics logo

About CanniMed Therapeutics Stock (TSE:CMED)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
52,208 shs
Average Volume
387,394 shs
Market Capitalization
C$668.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CanniMed Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CMED Stock News Headlines

ALDX Aldeyra Therapeutics, Inc.
CanniMed Therapeutics Inc (CMED)
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
See More Headlines

CMED Stock Analysis - Frequently Asked Questions

Shares of CMED stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that CanniMed Therapeutics investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Smith & Nephew (SNN), CannTrust (CTST), Hydropothecary (THCX), CannaRoyalty (CNNRF) and Cronos Group (CRON).

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Electronic Computer Manufacturing
Sub-Industry
Cannabis
Current Symbol
TSE:CMED
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
24,757,000
Free Float
N/A
Market Cap
C$668.44 million
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (TSE:CMED) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners